Skip to main content
PRVA
NASDAQ Industrial Applications And Services

Privia Health Q2 Revenue Jumps 21% to $633M, Net Income Triples; Credit Facility Doubled to $250M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$24
Mkt Cap
$3.019B
52W Low
$19.08
52W High
$28.82
52W Position info
26% above low
Off High info
17% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

PRVA sits 26% above its 52-week low of $19.08.

Summary

Privia Health reported Q2 2026 revenue of $632.6M (+21.4% YoY) and net income of $9.0M (+236.7% YoY), driven by strong provider and patient growth. The company also doubled its credit facility to $250M and disclosed an OIG inquiry into a former practice.


Key Events · Earnings and Guidance · PRVA

  • Q2 Revenue +21% to $632.6M

    Revenue grew 21.4% YoY to $632.6 million, driven by a 24.5% increase in FFS-patient care and a 26% jump in capitated revenue. Implemented Providers rose 10.1% to 5,644, and Attributed Lives increased 19.2% to 1.65 million.

  • Net Income Triples to $9.0M

    Net income attributable to Privia surged 236.7% to $9.0 million, or $0.07 per diluted share, as operating income expanded to $11.8 million from $3.3 million a year ago.

  • Adjusted EBITDA Up 29% to $37.4M

    Adjusted EBITDA rose 29.1% to $37.4 million, with margin expanding to 28.3% from 25.2%, reflecting operating leverage as the platform scales.

  • Credit Facility Doubled to $250M

    The revolving credit facility was amended to increase capacity to $250 million and extend maturity to 2031, providing significant liquidity for growth and acquisitions. No amounts were drawn as of June 30.


Analysis · PRVA · Industrial Applications And Services

Privia Health delivered a standout quarter, with revenue surging 21% to $632.6 million and net income more than tripling to $9.0 million. The company is scaling efficiently — Adjusted EBITDA rose 29% to $37.4 million, and key operating metrics like Implemented Providers and Attributed Lives grew double digits. The doubling of the credit facility to $250 million provides ample liquidity for expansion, while the CEO's termination of a pre-set trading plan removes a potential overhang. The only blemish is a disclosed OIG inquiry into a single former practice, though management does not expect a material impact.

At the time of this filing, PRVA was trading at $24.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $19.08 to $28.82. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRVA - Latest Insights

PRVA
Aug 06, 2026, 6:23 AM EDT
Filing Type: 8-K
Importance Score:
8
PRVA
Aug 06, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
PRVA
May 07, 2026, 8:58 AM EDT
Filing Type: 10-Q
Importance Score:
8
PRVA
May 07, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
PRVA
May 07, 2026, 6:06 AM EDT
Source: Dow Jones Newswires
Importance Score:
7